Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy
Condition: Prostate Cancer Metastatic to Bone Interventions: Drug: Radium-223 chloride; Drug: Rhenium-188-HEDP Sponsor: VU University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials